Redefining Haemostasis in Minimally Invasive Surgery: Surgi-ORC® Powder

Surgi-ORC® Powder supports smooth Minimally Invasive Surgery workflows with dependable haemostasis.

Redefining Haemostasis in Minimally Invasive Surgery: Surgi-ORC® Powder

Minimally invasive surgical (MIS) like endoscopic and laparoscopic surgery use a small camera-equipped tube to treat or diagnose internal conditions without large incisions. In these procedures, achieving haemostasis is essential. Even minor bleeding can obscure visibility, slow the operation, increase transfusion needs and if bleeding uncontrolled, place the patient at serious risk.1

This is where Surgi-ORC®, an effective haemostat, helps control oozing, reduces blood loss. Keep the field clear for safer and smoother procedures.

What is Surgi-ORC® Powder?
Surgi-ORC® Powder is a sterile, natural, plant-based absorbable oxidized regenerated cellulose (ORC) endoscopic powder designed to achieve effective haemostasis when applied directly to bleeding tissue or site. The powder format allows uniform dispersion and easy application in endoscopic, laparoscopic, or open surgical procedures.

What makes Surgi-ORC® Powder special?
- Rapid & Absorbable: Provides quick, effective haemostasis across various surgical procedures
- Bactericidal Action: Its low pH helps prevent bacterial growth, including antibiotic-resistant pathogens, reducing the risk of infection
- Safe Composition: Free from animal-derived materials, reducing allergy risk
- Precise Coverage: Flowable powder allows even application in deep or irregular areas, maintaining effective haemostasis even during irrigation
- Tissue-Friendly: Minimizes the need for cautery or sutures and promotes faster healing.

What are the key benefits for surgeons?
- Simplified application during minimally invasive procedures
- Reduced intraoperative bleeding and operative time
- Enhanced visualization for precise dissection
- Fewer postoperative complications such as hematoma, adhesion or infection
- Predictable absorption & biocompatibility ensure patient safety

Real-world clinical evidence and applications:

Real-world evidence

In a prospective, open-label, single-arm multicenter trial involving 103 patients, SURGICEL® Powder achieved haemostasis rates of 77.7%, 87.4%, and 92.2% at 3, 5, and 10 minutes, demonstrating safety, effectiveness, and ease of use across various surgical procedures.4

Conclusion

Surgi-ORC® Powder makes bleeding control in MIS simpler and more reliable. By providing quick haemostasis, improving visibility and demonstrating strong safety in clinical use. It gives surgeons greater confidence and helps patients recover faster and more safely.

References

1. Ricciardi S, Patel AJ, Alunni Fegatelli D, Volpi S, Femia F, Petrella L, Bille A, Cardillo G. Absorbable Powder Haemostat Use in Minimally Invasive Thoracic Surgery. Journal of Clinical Medicine. 2024 Dec 27;14(1):8
2. Kanagal, Deepa & Rao, Karthik & Gathoga, Peter & Moharana, Kabir & Patil, Rajas & Jaiswal, Purva & AP, Venkataraman. (2025). Biomaterial-Based Hemostasis: A Review of the Clinical and Functional Versatility of Oxidized Regenerated Cellulose. Cureus. 10.7759/cureus.94602.
3. Auslands K, Kocane E, Bergfelde E, Valeinis E, Dolgopolova J, Aksiks J, Aksiks I. Evaluation of the Performance of StypCelTM Absorbable Hemostat for Intraoperative Hemorrhage Control in Neurosurgery: A Multicenter, Single-Arm Study in Riga, Latvia. Medicina. 2025 Oct 16;61(10):1862.
4. Al-Attar N, de Jonge E, Kocharian R, Ilie B, Barnett E, Berrevoet F. Safety and hemostatic effectiveness of SURGICEL® powder in mild and moderate intraoperative bleeding. Clinical and Applied Thrombosis/Hemostasis. 2023 Jul;29:10760296231190376.